Status:

COMPLETED

Client-led Online Therapy for People Diagnosed With Bipolar Disorder

Lead Sponsor:

University of Manchester

Conditions:

Bipolar Spectrum Disorder

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The study aims to investigate the use of Method of Levels therapy (MOL) delivered online via videoconferencing for people who have received a diagnosis of a bipolar spectrum disorder. People are typic...

Detailed Description

Bipolar spectrum disorder (previously known as manic depression) is a diagnostic term used to describe experiences of extreme, and sometimes enduring, fluctuations in mood that interfere with a person...

Eligibility Criteria

Inclusion

  • People aged 18 years and over
  • Individuals with a diagnosis of Bipolar Spectrum Disorder.
  • People accessing services or third sector agencies and/ or living in England.
  • Access to personal use of technology is required for online therapy.

Exclusion

  • People presenting with extreme risk to self or others and engaging in active suicidal thoughts and/or behaviours.
  • Problems of an organic nature, such as a brain injury or learning disability that might affect cognitive functioning.
  • People already receiving a talking therapy for their difficulties
  • People unable to speak/ understand sufficient English.
  • Anyone already receiving talking therapy at the time of enrolment
  • Anyone with a diagnosis of schizophrenia, schizoaffective disorder, primary substance misuse (mood swings caused purely by substance misuse), or psychosis outside of mood episodes or current episode of mania.
  • People who do not have access to the internet and a video calling device.

Key Trial Info

Start Date :

June 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 31 2022

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT04859647

Start Date

June 1 2021

End Date

January 31 2022

Last Update

May 19 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The University of Manchester

Manchester, United Kingdom